loading
Forte Biosciences Inc stock is traded at $7.35, with a volume of 13,337. It is down -1.08% in the last 24 hours and down -19.23% over the past month.
See More
Previous Close:
$7.43
Open:
$7.21
24h Volume:
13,337
Relative Volume:
0.30
Market Cap:
$47.50M
Revenue:
-
Net Income/Loss:
$-31.48M
P/E Ratio:
-7.0673
EPS:
-1.04
Net Cash Flow:
$-28.71M
1W Performance:
-10.37%
1M Performance:
-19.23%
6M Performance:
+43.98%
1Y Performance:
-59.03%
1-Day Range:
Value
$7.21
$7.98
1-Week Range:
Value
$7.10
$9.04
52-Week Range:
Value
$4.11
$28.68

Forte Biosciences Inc Stock (FBRX) Company Profile

Name
Name
Forte Biosciences Inc
Name
Phone
(310) 618-6994
Name
Address
3060 PEGASUS PARK DRIVE, DALLAS, CA
Name
Employee
0
Name
Twitter
Name
Next Earnings Date
2024-11-11
Name
Latest SEC Filings
Name
FBRX's Discussions on Twitter

Compare FBRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
FBRX
Forte Biosciences Inc
7.35 47.50M 0 -31.48M -28.71M -1.04
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
483.49 124.48B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
625.60 67.45B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
583.62 35.60B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
266.83 34.53B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
274.78 29.15B 3.81B -644.79M -669.77M -6.24

Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-21-25 Initiated TD Cowen Buy
Apr-08-24 Upgrade Ladenburg Thalmann Neutral → Buy
Sep-20-21 Upgrade Chardan Capital Markets Sell → Buy
Sep-03-21 Downgrade B. Riley Securities Buy → Neutral
Sep-03-21 Downgrade Chardan Capital Markets Buy → Sell
Sep-03-21 Downgrade Ladenburg Thalmann Buy → Neutral
Sep-03-21 Downgrade Truist Buy → Hold
May-14-21 Initiated B. Riley Securities Buy
Mar-26-21 Initiated Citigroup Buy
Aug-28-20 Upgrade Chardan Capital Markets Neutral → Buy
Aug-25-20 Initiated Truist Buy
View All

Forte Biosciences Inc Stock (FBRX) Latest News

pulisher
02:29 AM

Forte Biosciences Sees Unusually Large Options Volume (NASDAQ:FBRX) - Defense World

02:29 AM
pulisher
01:28 AM

Chardan Capital Issues Pessimistic Forecast for Forte Biosciences (NASDAQ:FBRX) Stock Price - Defense World

01:28 AM
pulisher
Apr 02, 2025

Chardan Adjusts Price Target on Forte Biosciences to $61 From $64, Maintains Buy Rating - MarketScreener

Apr 02, 2025
pulisher
Apr 02, 2025

Forte Biosciences Reports 2024 Progress and Financials - TipRanks

Apr 02, 2025
pulisher
Apr 01, 2025

Is Forte Biosciences (NASDAQ:FBRX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance

Apr 01, 2025
pulisher
Mar 31, 2025

Forte's Celiac Treatment Shows Promise: Zero Dropouts and $58.4M War Chest - Stock Titan

Mar 31, 2025
pulisher
Mar 31, 2025

Forte Biosciences, Inc. Announces Results and Provides Clinical Update - Bluefield Daily Telegraph

Mar 31, 2025
pulisher
Mar 28, 2025

Forte Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Forte Biosciences Inc Files For Mixed Shelf Of Up To $300 MillionSEC Filing - MarketScreener

Mar 28, 2025
pulisher
Mar 28, 2025

Forte Biosciences, Inc. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

Forte Biosciences Inc. (FBRX) reports earnings - Quartz

Mar 28, 2025
pulisher
Mar 27, 2025

(FBRX) Long Term Investment Analysis - news.stocktradersdaily.com

Mar 27, 2025
pulisher
Mar 25, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Mar 25, 2025
pulisher
Mar 15, 2025

FORTE BIOSCIENCES Earnings Preview: Recent $FBRX Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 15, 2025
pulisher
Mar 15, 2025

Forte Biosciences (FBRX) to Release Earnings on Monday - The AM Reporter

Mar 15, 2025
pulisher
Mar 14, 2025

Forte Biosciences Inc expected to post a loss of $3.27 a shareEarnings Preview - TradingView

Mar 14, 2025
pulisher
Mar 14, 2025

Forte Biosciences, Inc. (NASDAQ:FBRX) Sees Large Drop in Short Interest - Defense World

Mar 14, 2025
pulisher
Mar 10, 2025

Forte Biosciences (FBRX) Expected to Announce Quarterly Earnings on Monday - Defense World

Mar 10, 2025
pulisher
Mar 06, 2025

Stock Traders Purchase Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - The AM Reporter

Mar 06, 2025
pulisher
Mar 06, 2025

Traders Purchase High Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World

Mar 06, 2025
pulisher
Feb 28, 2025

Forte Biosciences, Inc. (NASDAQ:FBRX) Short Interest Update - MarketBeat

Feb 28, 2025
pulisher
Feb 25, 2025

Forte Biosciences Stock Down 20% But Insiders Still In US$92k Profit - Simply Wall St

Feb 25, 2025
pulisher
Feb 24, 2025

Pre-market Movers: ISPC, TH, IVVD, TOVX... - RTTNews

Feb 24, 2025
pulisher
Feb 23, 2025

(FBRX) On The My Stocks Page - news.stocktradersdaily.com

Feb 23, 2025
pulisher
Feb 23, 2025

Stock Traders Buy Large Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat

Feb 23, 2025
pulisher
Feb 20, 2025

Evelo Biosciences Target of Unusually Large Options Trading (NASDAQ:EVLO) - Defense World

Feb 20, 2025
pulisher
Feb 19, 2025

One Forte Biosciences Insider Raised Stake By 273% In Previous Year - Yahoo Finance

Feb 19, 2025
pulisher
Feb 14, 2025

Best Stocks Under $20 Right Now - Benzinga

Feb 14, 2025
pulisher
Feb 12, 2025

Where are the Opportunities in (FBRX) - Stock Traders Daily

Feb 12, 2025
pulisher
Feb 09, 2025

Stock Traders Buy High Volume of Call Options on Forte Biosciences (NASDAQ:FBRX) - MarketBeat

Feb 09, 2025
pulisher
Feb 06, 2025

Forte Biosciences Sees Unusually High Options Volume (NASDAQ:FBRX) - Defense World

Feb 06, 2025
pulisher
Feb 03, 2025

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings -February 03, 2025 at 09:03 am EST - Marketscreener.com

Feb 03, 2025
pulisher
Feb 03, 2025

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings - Business Wire

Feb 03, 2025
pulisher
Feb 01, 2025

(FBRX) Proactive Strategies - Stock Traders Daily

Feb 01, 2025
pulisher
Jan 30, 2025

CSG Forte Wins TSG Real Transaction Metrics Awards for Second Consecutive Year - Yahoo Finance

Jan 30, 2025
pulisher
Jan 25, 2025

Forte Biosciences expands equity incentive plan By Investing.com - Investing.com Australia

Jan 25, 2025
pulisher
Jan 25, 2025

TD Cowen initiates Forte Biosciences stock with Buy rating - MSN

Jan 25, 2025
pulisher
Jan 24, 2025

Forte Biosciences expands equity incentive plan - MSN

Jan 24, 2025
pulisher
Jan 23, 2025

Traders Purchase Large Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World

Jan 23, 2025
pulisher
Jan 23, 2025

Meiwu Technology (NYSE:WNW) Stock Price Down 13.2% – Here’s Why - Defense World

Jan 23, 2025
pulisher
Jan 22, 2025

Forte Biosciences (NASDAQ:FBRX) Coverage Initiated by Analysts at TD Cowen - Defense World

Jan 22, 2025
pulisher
Jan 21, 2025

TD Cowen initiates Forte Biosciences stock with Buy rating By Investing.com - Investing.com Australia

Jan 21, 2025
pulisher
Jan 21, 2025

Atopic Dermatitis Drugs Market Trends Analysis Report - GlobeNewswire

Jan 21, 2025
pulisher
Jan 11, 2025

(FBRX) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Jan 11, 2025
pulisher
Jan 09, 2025

Forte Biosciences Target of Unusually High Options Trading (NASDAQ:FBRX) - Defense World

Jan 09, 2025
pulisher
Jan 06, 2025

Forte Biosciences (FBRX) Is a Great Choice for 'Trend' Investors, Here's Why - MSN

Jan 06, 2025
pulisher
Dec 31, 2024

(FBRX) Technical Data - Stock Traders Daily

Dec 31, 2024
pulisher
Dec 26, 2024

Investors Purchase Large Volume of Put Options on Evelo Biosciences (NASDAQ:EVLO) - Defense World

Dec 26, 2024
pulisher
Dec 26, 2024

Investors Buy High Volume of Forte Biosciences Call Options (NASDAQ:FBRX) - Defense World

Dec 26, 2024
pulisher
Dec 20, 2024

100 cell and gene therapy leaders to watch in 2025 - Drug Discovery & Development

Dec 20, 2024
pulisher
Dec 16, 2024

Why Forte Biosciences (FBRX) Stock Is Trading Lower - Benzinga

Dec 16, 2024

Forte Biosciences Inc Stock (FBRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$73.44
price up icon 2.00%
$68.32
price up icon 0.56%
$31.28
price up icon 0.35%
$20.46
price up icon 8.83%
$93.32
price up icon 3.36%
biotechnology ONC
$274.78
price up icon 1.38%
Cap:     |  Volume (24h):